News Buzz : Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), VIVUS Inc. (NASDAQ:VVUS), Miller Energy Resources, Inc. (NYSE:MILL), RCS Capital Corporation (NYSE:RCAP), Fred’s, Inc. (NASDAQ:FRED),

Ariad Pharmaceuticals (NASDAQ:ARIA Director Sarah J. Schlesinger bought 5,200 shares of Ariad Pharmaceuticals stock on the open market in a transaction that occurred on Wednesday, September 10th. The shares were purchased at an average cost of $5.73 per share, with a total value of $29,796.00. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) belongs to Healthcare sector. Its weekly performance is -3.27%. On last trading day company shares ended up $5.62. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) distance from 50-day simple moving average (SMA50) is -3.48%.

On Sep 19, VIVUS Inc. (NASDAQ:VVUS) and Auxilium Pharmaceuticals, Inc. ( AUXL ) announced that the FDA has approved their erectile dysfunction (ED) drug, Stendra’s (EU trade name: Spedra) supplemental new drug application (sNDA) to include 15 minutes onset of action. VIVUS Inc. (NASDAQ:VVUS) shares moved up 2.16% in last trading session and ended the day at $4.25. VVUS Gross Margin is 84.20% and its return on assets is -25.50%. VIVUS Inc. (NASDAQ:VVUS) quarterly performance is -19.81%.

Miller Energy Resources (NASDAQ:MILL) CEO Carl Fredrick Giesler acquired 20,000 shares of the company’s stock on the open market in a transaction dated Friday, September 19th. The shares were purchased at an average price of $4.89 per share, for a total transaction of $97,800.00. Following the completion of the transaction, the chief executive officer now directly owns 660,000 shares in the company, valued at approximately $3,227,400. On 22 September, Miller Energy Resources, Inc. (NYSE:MILL) shares decreased -4.73% and was closed at $4.63. MILL EPS growth in last 5 year was -29.80%. Miller Energy Resources, Inc. (NYSE:MILL) year to date (YTD) performance is -34.23%.

RCS Capital Corp (NASDAQ:RCAP) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research note issued on Wednesday. They currently have a $25.30 price objective on the stock . Zacks‘s price objective would suggest a potential upside of 3.65% from the company’s current price. RCS Capital Corporation (NYSE:RCAP) ended the last trading day at $23.34. Company weekly volatility is calculated as 3.70% and price to cash ratio as 3.39. RCS Capital Corporation (NYSE:RCAP) showed a weekly performance of -2.75%.

Fred’s, Inc. (NASDAQ:FRED) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C. Fred’s, Inc. (NASDAQ:FRED) shares decreased -1.30% in last trading session and ended the day at $14.42. FRED Gross Margin is 27.20% and its return on assets is 0.10%. Fred’s, Inc. (NASDAQ:FRED) quarterly performance is -3.55%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone